InsiderPulse| Date | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-29 | Ladd Amy L | Director | Sale | 119 | $463.50 | $55K | 120 | View ↗ | |
| 2026-04-28 | Ladd Amy L | Director | Sale | 500 | $473.46 | $237K | 239 | View ↗ | |
| 2025-09-04 | Ladd Amy L | Director | Sale | 335 | $440.69 | $148K | 739 | View ↗ | |
| 2025-09-03 | Ladd Amy L | Director | Sale | 336 | $470.11 | $158K | 1,074 | View ↗ | |
| 2025-04-30 | Ladd Amy L | Director | Sale | 8,776 | $505.55 | $4.44M | 1,410 | View ↗ |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total revenue | $1.57B+20.3% | $1.31B+11.9% | $1.17B+14.0% | $1.02B+11.8% | $916.2M |
| Total cost of revenue | $556.3M+37.4% | $404.8M+14.7% | $352.8M+8.3% | $325.9M+13.4% | $287.5M |
| Gross profit | $6.64B+17.9% | $5.63B+19.1% | $4.73B+12.7% | $4.20B+6.0% | $3.96B |
| Selling, general and administrative | $2.38B+11.4% | $2.14B+9.0% | $1.96B+12.9% | $1.74B+18.6% | $1.47B |
| Research and development | $1.31B+14.5% | $1.15B+14.7% | $998.8M+13.6% | $879.0M+31.0% | $671.0M |
| Total operating expenses | $3.70B+12.5% | $3.29B+10.9% | $2.96B+13.1% | $2.62B+22.5% | $2.14B |
| Income from operations | $2.95B+25.4% | $2.35B+32.9% | $1.77B+12.0% | $1.58B-13.4% | $1.82B |
| Interest and other income, net | $365.9M+12.6% | $324.9M+69.1% | $192.1M+546.8% | $29.7M-57.1% | $69.3M |
| Income before taxes | $3.31B+23.8% | $2.67B+36.5% | $1.96B+21.9% | $1.61B-15.0% | $1.89B |
| Income tax expense | $434.8M+29.3% | $336.3M+137.5% | $141.6M-46.0% | $262.4M+61.8% | $162.2M |
| Net income | $2.88B+23.1% | $2.34B+28.6% | $1.82B+35.2% | $1.34B-22.2% | $1.73B |
| Less: net income attributable to noncontrolling interest in joint venture | $20.6M+38.3% | $14.9M-22.8% | $19.3M-12.7% | $22.1M-6.0% | $23.5M |
| Net income attributable to Intuitive Surgical, Inc. | $2.86B+23.0% | $2.32B+29.2% | $1.80B+36.0% | $1.32B-22.4% | $1.70B |
| Basic (usd per share) | $8.0M+22.3% | $6.5M+27.7% | $5.1M+37.6% | $3.7M-22.3% | $4.8M |
| Diluted (usd per share) | $7.9M+22.6% | $6.4M+27.6% | $5.0M+37.8% | $3.6M-21.7% | $4.7M |
| Basic (shares) | $356.9M+0.5% | $355.2M+1.1% | $351.2M-1.3% | $355.7M-0.1% | $356.1M |
| Diluted (shares) | $362.7M+0.2% | $362.0M+1.3% | $357.4M-1.3% | $362.0M-1.0% | $365.8M |
| Joint venture | |||||
| Less: net income attributable to noncontrolling interest in joint venture | $20.6M+38.3% | $14.9M-22.8% | $19.3M-12.7% | $22.1M-6.0% | $23.5M |
| Product | |||||
| Total revenue | $1.57B+20.3% | $1.31B+11.9% | $1.17B+14.0% | $1.02B+11.8% | $916.2M |
| Total cost of revenue | $556.3M+37.4% | $404.8M+14.7% | $352.8M+8.3% | $325.9M+13.4% | $287.5M |
| Service | |||||
| Total revenue | $1.57B+20.3% | $1.31B+11.9% | $1.17B+14.0% | $1.02B+11.8% | $916.2M |
| Total cost of revenue | $556.3M+37.4% | $404.8M+14.7% | $352.8M+8.3% | $325.9M+13.4% | $287.5M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Is ISRG's International Weakness a Temporary Drag or Structural Risk?
5 Revealing Analyst Questions From Intuitive Surgical’s Q1 Earnings Call
How Strong Q1 2026 Results and Completed Buyback Will Impact Intuitive Surgical (ISRG) Investors
Medical Robotics Market Size to Grow USD 102.75 Billion by 2035 | Research by SNS Insider
Medtronic: Expectations Are Low And That's The Opportunity
Why Intuitive Surgical Is a Strong Buy as Robotic Surgery Adoption Accelerates
Is Trending Stock Intuitive Surgical, Inc. (ISRG) a Buy Now?
SquareMind Raises $18 Million to Redefine Skin Exams With Robotics and AI
Intuitive Surgical vs Boston Scientific: Which Stock Is the Better Buy Post Q1?
Medtronic: Is This Dividend Aristocrat Finally A 'Buy' Before Earnings?
Intuitive Surgical: Forget The 40x P/E. Focus On The 10-Year Potential (Upgrade)
Intuitive Surgical Is A Buy Despite Soaring Post-Earnings